Jeff Yass’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
Other funds holding RYTM
BBA
Jeff Yass's RYTM Position: Q3 2026 in Review
Jeff Yass increased its Rhythm Pharmaceuticals (RYTM) stake by 432% in Q3 2026, buying an estimated $2.01M and bringing the position to 23,245 shares worth $2.21M. The position accounts for ﹤0.01% of the portfolio, ranked #6053.
Jeff Yass first reported a position in RYTM in Q2 2019 and has held it in 29 quarters since. The position peaked at $20.2M in Q4 2022. 328 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.
- Jeff Yass held 23,245 shares of Rhythm Pharmaceuticals worth $2.21M as of Q3 2026.
- Jeff Yass bought 18,873 Rhythm Pharmaceuticals shares in Q3 2026, an estimated $2.01M.
- Rhythm Pharmaceuticals made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #6053 holding.
- Jeff Yass first reported a position in Rhythm Pharmaceuticals in Q2 2019 and has held it in 29 quarters since.
- Jeff Yass's Rhythm Pharmaceuticals position peaked at $20.2M in Q4 2022.
- 328 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.